Atlas Trials

Safety of Tuberculosis Vaccine, MVA85A, Administered by the Intramuscular Route and the Intradermal Route

Clinical trial NCT01181856 · COMPLETED

Trial details

NCT number
NCT01181856
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Tuberculosis
Start date
2010-01-01
Primary completion
2011-01-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.